Bill
Bill > SB67
PA SB67
PA SB67Requiring health insurance policies to provide coverage for postexposure prophylaxis HIV medication.
summary
Introduced
03/11/2021
03/11/2021
In Committee
03/11/2021
03/11/2021
Crossed Over
Passed
Dead
11/30/2022
11/30/2022
Introduced Session
2021-2022 Regular Session
Bill Summary
An Act requiring health insurance policies to provide coverage for postexposure prophylaxis HIV medication.
AI Summary
This bill requires health insurance policies in Pennsylvania to provide coverage for postexposure prophylaxis (PEP) HIV medication. PEP is a medication approved by the FDA that can be taken to prevent the transmission of HIV after potential exposure. The bill prohibits insurance providers from moving PEP HIV medication into a specialty tier solely for financial reasons, and it also prohibits requiring counseling from an infectious disease specialist or immunologist to receive the medication unless medically necessary. The bill will take effect 60 days after it is enacted.
Committee Categories
Business and Industry
Sponsors (10)
Katie Muth (D)*,
Amanda Cappelletti (D),
Maria Collett (D),
Carolyn Comitta (D),
Jay Costa (D),
Wayne Fontana (D),
Tim Kearney (D),
Steve Santarsiero (D),
Sharif Street (D),
Tina Tartaglione (D),
Last Action
Referred to BANKING AND INSURANCE (on 03/11/2021)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2021&sind=0&body=S&type=B&bn=67 | 03/12/2021 |
| Bill | https://www.legis.state.pa.us/cfdocs/legis/PN/Public/btCheck.cfm?txtType=PDF&sessYr=2021&sessInd=0&billBody=S&billTyp=B&billNbr=0067&pn=0393 | 03/12/2021 |
Loading...